We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
14:10 - 15:10
A1 Plenary
Highlights: Latest Trials
Matthias Guckenberger, Switzerland;
Ugur Selek, Turkey
Proffered Papers
Interdisciplinary
14:10 - 14:20
ARCHERY: a global trial evaluating artificial intelligence (AI) based radiotherapy treatment: results for cervix and prostate cancer (NCT05653063)
Ajay Aggarwal, United Kingdom
-5494
14:20 - 14:30
Health-related quality of life in the phase III trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010)
Matthew Tyler, United Kingdom
-696
14:40 - 14:50
Combination of L19-IL2 immunocytokine & SABR for stage IV NSCLC with limited metastatic burden: the randomized, multicentre, phase II ImmunoSABR trial
Philippe Lambin, The Netherlands
-5597
14:50 - 15:00
Personalising Radiotherapy Dose in Anal Cancer (PLATO) Platform: 6-month patient reported outcomes across ACT3, ACT4 and ACT5 trials
Alexandra Gilbert, United Kingdom
-3983
15:00 - 15:10
Individual patient data meta-analysis of anti-EGFR monoclonal antibodies in locoregionally advanced head and neck cancers: final analysis of MACH-EGFR
Pierre Blanchard, France
-5506